Utilization of Steroid Sparing Agents for Immune-Related Adverse Events (irAEs): Management Strategies and Considerations

Current Oncology Reports 2026

View at publisher
Authors: Sherin Juliet Rouhani, Matthew James Hadfield, Matthew M. Lei, Ross D. Merkin, Michael Lawrence Dougan, Gabriela Soriano Hobbs, Sarah P. Hammond, Kerry Lynn Reynolds
DOI: 10.1007/s11912-026-01737-y
Cited by: 1
References: 122

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Prostate Cancer Treatment and Research Adrenal Hormones and Disorders

Publication details

Journal / source
Current Oncology Reports
Publisher
Springer Science and Business Media LLC
Volume
28
Issue
1
Pages
12–12
Publication date
7 February 2026
Language
EN